Who Pays? Coverage Challenges for Cardiovascular Genetic Testing in U.S. Patients
Inherited cardiovascular conditions are common, and comprehensive care of affected families often involves genetic testing. When the clinical presentations of these conditions overlap, genetic testing may clarify diagnoses, etiologies, and treatments in symptomatic individuals and facilitate the ide...
Main Authors: | Katherine Grace Spoonamore, Nicole M Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-05-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fcvm.2016.00014/full |
Similar Items
-
Why Insurers Are Wrong about Adverse Selection
by: R. Guy Thomas
Published: (2018-04-01) -
Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized Medicine
by: Sahana Aiyer, et al.
Published: (2023-05-01) -
An Evolutionary Generation Method of Test Data for Multiple Paths Based on Coverage Balance
by: Shuping Fan, et al.
Published: (2021-01-01) -
ShareDNA: a smartphone app to facilitate family communication of genetic results
by: Chethan Jujjavarapu, et al.
Published: (2021-01-01) -
Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis
by: Candace L. Jackson, et al.
Published: (2021-12-01)